Evaluation of 2 Intensification Treatment Strategies for Neuroblastoma Patients With a Poor Response to Induction
Stopped The Sponsor has been notified of an interruption in the international supply, and there is a possibility that 131I-mlBG would be unavailable to patients randomised to arm A of the trial
Conditions
- Very High Risk Neuroblastoma
Interventions
- RADIATION: mIBG
- DRUG: Topotecan
- DRUG: Thiotepa
- PROCEDURE: Autologous stem cell transplant
Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Collaborators